|
|
Gene Symbol |
AIFM1 |
|
Aliases |
AIF, AUNX1, CMT2D, CMTX4, COWCK, COXPD6, DFNX5, NADMR, NAMSD, PDCD8, SEMDHL |
|
Entrez Gene ID |
|
|
Gene Name |
Apoptosis inducing factor mitochondria associated 1 |
|
Chromosomal Location |
Xq26.1 |
|
HGNC ID |
|
|
Summary |
This gene encodes a flavoprotein essential for nuclear disassembly in apoptotic cells, and it is found in the mitochondrial intermembrane space in healthy cells. Induction of apoptosis results in the translocation of this protein to the nucleus where it affects chromosome condensation and fragmentation. In addition, this gene product induces mitochondria to release the apoptogenic proteins cytochrome c and caspase-9. Mutations in this gene cause combined oxidative phosphorylation deficiency 6 (COXPD6), a severe mitochondrial encephalomyopathy, as well as Cowchock syndrome, also known as X-linked recessive Charcot-Marie-Tooth disease-4 (CMTX-4), a disorder resulting in neuropathy, and axonal and motor-sensory defects with deafness and cognitive disability. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 10. [provided by RefSeq, Aug 2015]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Apoptosis-inducing factor 1, mitochondrial, apoptosis-inducing factor, mitochondrion-associated, 1, auditory neuropathy, X-linked recessive 1, programmed cell death 8 (apoptosis-inducing factor), striatal apoptosis-inducing factor, testicular secretory protein Li 4 |
|
Function |
|
|
|
|
|
UniProt |
|
|
PDB |
1M6I, 4BUR, 4BV6, 4FDC, 4LII, 5FMH, 5FS6, 5FS7, 5FS8, 5FS9, 5KVH, 5KVI |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000287295 |
O95831 |
O95831 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Cardiovascular Abnormalities |
|
Cardiomyopathy |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Frontometaphyseal dysplasia |
|
Charcot-Marie-Tooth Disease |
|
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Skin Cancer |
|
Nervous System Diseases |
Neuropathy |
|
Childhood Ataxia with Central Nervous System Hypomyelinization |
|
MELAS Syndrome |
|
Spinocerebellar ataxia |
|
Encephalopathies |
|
Psychiatric/Brain disorders |
Alzheimer Disease |
|
Neurodevelopmental Disorders |
|
Cognition Disorders |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
|
PCOS, Apoptosis |
|
Rotterdam Criteria |
Direct
|
3 PCOS patients and 3 non- PCOS patients |
LGCs from PCOS cells treated with Cb2 present more significant changes at the transcriptomiclevel than non-PCOS cells. To validate whether there were significant differences between Cb2-treated and -untreated samples, seven key genes were selected by GSEA analysis, The RT-qPCR results for all validated genes showed the same trend as found in the microarray experiment, confirming the microarray data. In addition, most of the changes were significant (P value <0.05). |
|
|
|